NAD+ injections: costs, evidence and access

Compare current NAD+ cost examples by exact supply and commitment, then read the route-specific evidence. A clinician and identifiable dispensing pharmacy allow basic checks; they do not establish a wellness benefit. Use the provider checklist before an order and the billing calculator before prepaying.

NAD+ is the molecule, NMN and NR are its building blocks

NAD+ is a coenzyme your cells already make and use constantly. Injections deliver the molecule itself; NMN and NR are pills your body converts into it.

That's the key split. Oral precursors raise blood NAD in trials, and they're sold as supplements: see NMN and NMN or NR. Injected NAD+ skips the conversion step, but how much reaches your tissues, rather than just your blood, hasn't been established.

Why people try NAD+ injections, and what's been tested for each goal

For the consumer goals below, research on these home NAD+ preparations does not establish a reliable treatment benefit. The table distinguishes clinical measurements from wellness claims.

The systematic review found most eligible human intervention evidence concerned oral precursors. Those studies showed biochemical changes, with mixed or often null clinical outcomes; they do not establish an injection benefit ^[6].

What human studies measured, and what they cannot establish

The literature includes a small controlled infusion study, a randomized heart-failure trial, retrospective IV tolerability observations and uncontrolled mixed-treatment neurological reports. A systematic review searching through October 2025 found no eligible IV or intramuscular NAD+ anti-aging/wellness outcome trial. Those are different questions and study designs, not interchangeable evidence for a home kit.

• Grant 2019. Eight men received NAD+ and three saline during a six-hour pharmacokinetic pilot. Plasma NAD+ did not rise for the first two hours; urinary NAD+ and methyl-nicotinamide increased by six hours. This was chemistry, not a wellness endpoint, and some authors had NAD+ business affiliations ^[4].
• Yu 2026, heart-failure trial. 180 adults with heart failure from ischemic heart disease got a 7-day IV course or placebo on top of standard care. Ejection fraction at 1 month was 45.44% vs 42.44%. Major heart events at 6 months were 14.6% vs 24.7%, not a significant difference ^[5].
• Gallagher 2026. The review included 113 eligible studies, including 33 human studies (28 randomized) and found no eligible IV or intramuscular NAD+ anti-aging/wellness outcome trial in its search through October 2025. Oral precursor studies cannot establish injection or spray benefit. The first author discloses a relationship with a company serving an aesthetics clinic that does not offer NAD+ ^[6].
• Reyna 2026. A retrospective commercial-clinic comparison of IV NAD+ and NR reported gut symptoms, faster heart rate and chest pressure during NAD+ infusions, resolving after stopping. It was not randomized wellness efficacy research and does not establish home-route adverse-event rates ^[7].

The cited randomized NAD+ efficacy trial involved hospital patients with ischemic heart failure. That population, setting and endpoint do not establish improved energy, recovery or aging in a healthy person using a home preparation. The heart-event difference at six months was not statistically significant ^[5].

NADH is the reduced form of this redox pair, with its own evidence; it is not interchangeable clinical proof for NAD+ injections. An older open-label IV NADH report involved 34 Parkinson patients. A later double-blind study of five treated patients and four saline controls found no statistically significant clinical or biochemical benefit after its IV/IM protocol. Neither study establishes healthy anti-aging benefit or validates a commercial NAD+ product ^{[17] [18]}.

Category 1 is conditional evaluation, not drug approval

Category 1 means the nominated substance is under evaluation. FDA’s interim enforcement policy includes conditions concerning the material and applicable compounding requirements. A pharmacy license and prescription do not by themselves establish that every finished preparation or route qualifies ^{[2] [3]}.

Compare the supply and commitment before the price

Current offers quote different amounts and supply periods. Compare the prescribed quantity, price after the introductory period, actual renewal interval and total prepaid commitment. In-clinic IV services need a separate per-session and full-course quote.

Plan structure and prescribed quantity both matter. A prepaid discount exchanges flexibility for a longer commitment; a change in a laboratory marker does not establish a meaningful treatment benefit. The cost guide also explains AgelessRx’s introductory prepaid offer and differing campaign prices. Compare AgelessRx or HealthRX for service context.

Nasal spray: the needle-free option, with even less research

Human intranasal reports exist. A 2022 conference case used NAD+ with lidocaine through a catheter plus subsequent sublingual NAD+. A 2025 report followed three Parkinson patients after IV NAD+ and then intranasal NAD+/lidocaine. Neither had a control group or isolated a commercial spray’s effect; the latter’s improvement scale omitted a zero-improvement option. These observations do not establish energy, absorption or aging benefits from retail sprays ^{[8] [9]}.

At-home injection, nasal spray or IV drip

The cited programs offer home preparations after clinician review, with supply and renewal schedules that vary. IV services are administered at a clinic and require their own per-session and course quote. No controlled comparison establishing wellness equivalence among these routes was identified.

The controlled infusion pilot measured blood and urine chemistry, while later retrospective work described tolerability. These findings address different questions; neither establishes equivalence to home injections or nasal sprays. Read the route comparison for the populations and limitations.

How to get NAD+: a telehealth visit, then a pharmacy kit

An online program may coordinate intake, clinician review and pharmacy dispensing. Ask which testing is clinically appropriate for your history and whether it is included or extra; an absence of a published lab requirement is not proof that no evaluation is needed.

State availability varies, and so does how clearly programs name their pharmacy. The step-by-step, with what to ask before you pay, is in where to get NAD+ injections.

How long until you notice anything

No controlled study establishing a reliable personal timeline for these home-injection wellness offers was identified. A systematic review’s absence of eligible IV or intramuscular wellness trials applies to its October 2025 search cutoff, not to every human report ever published ^[6].

What studies did time, and how to judge your own response, is in how long NAD+ injections take to work.

NAD+ with other treatments

Some catalogs offer NAD+ alongside NMN, tirzepatide, sermorelin or glutathione. That co-listing does not establish that a pair adds benefit or is safe to combine. No controlled combination evidence applicable to these commercial wellness offers was identified.

• NMN. An oral precursor taken alongside NAD+. See NMN and NAD+ together.
• Tirzepatide. Some programs sell both. See NAD+ and tirzepatide together.
• Sermorelin. Often sold by the same programs. See sermorelin.
• Glutathione. Another compounded injection in the same catalogs. See NAD+ or glutathione and glutathione.

Retatrutide is investigational and is not an FDA-approved product that can simply be added to a commercial wellness plan. FDA says it cannot be used in compounding under federal law. Authorized clinical research or any applicable expanded-access process is a separate route, and trial registration alone is not authorization ^{[19] [20]}.

What to check on any NAD+ program before you pay

Ask these questions before paying, especially when a headline price covers a limited quantity or requires a prepaid commitment.

1. Renewal price. Confirm when an introductory price ends and the exact later charge.
2. Quantity and interval. Ask what is dispensed and whether renewal is every calendar month, 28 days, 30 days or a longer period. Supply duration and billing are different facts.
3. Required fees. Request the total including visits, testing, membership and shipping.
4. The pharmacy. Ask which licensed pharmacy will dispense your exact prescription and verify its license.
5. Cancellation. Read the offer-specific deadline and whether an order already sent to the pharmacy can be stopped or refunded.

Side effects and who should skip it

No FDA-approved NAD+ label establishes adverse-event frequencies for these preparations. Retrospective IV tolerability observations report symptoms during infusion, but they cannot establish the risk of a subcutaneous injection or nasal spray ^[7]. Oral NMN/NR tolerability also cannot substitute for direct-product safety evidence.

Discuss your health history, medicines and potential risks with the prescriber before treatment. An unapproved preparation has no FDA-reviewed product label to establish a universal screening rule, adverse-event rate or safe use across populations.

Ready to compare programs? Start with the energy shortlist, check cost guides, or take the quiz.